Revolut’s triumph reminds us what British tech sector is capable of March 12, 2026 There hasn’t been much good news around lately – between the UK’s miserable growth trajectory, war in the Middle East and the whiff of decay in Downing Street, it’s been hard to find the optimism. But when something genuinely impressive happens in British business, it’s worth pausing to take notice. And this week we had [...]
Nature Medicine Study Shows AI Outperforms Therapists on Cognitive Behavioral Therapy March 12, 2026 Randomized, double-blind trial shows Limbic’s clinical reasoning layer turns leading LLMs into mental health specialists, achieving gold-standard clinical performance
Level Access Supercharges Partner Program to Accelerate Digital Accessibility March 12, 2026 IBM, Slalom, Merkle, and more will harness the power of Level Access’s platform to deliver inclusive customer experiences
Redslim expands into Asia-Pacific to support global brands with data and AI infrastructure March 12, 2026 Redslim, a specialist in end-to-end data management solutions and an Astorg portfolio company, today announced its expansion into the Asia-Pacific region and the appointment of Kyriakos Zannikos as Regional Director, APAC. The move marks an important milestone in Redslim’s global growth strategy and brings the company closer to clients operating in one of the world’s [...]
On the Beach shares tumble as it tears up guidance amid bookings slowdown March 12, 2026 On the Beach has torn up its guidance for the forthcoming year after warning that tensions in the Middle East have sparked a sharp slowdown in bookings. The online travel agent previously forecast pre-tax profit of between £39m and £43m. “Whilst the group has limited exposure to destinations in the Middle East, it has experienced [...]
John Lewis reinstates staff bonus but remains ‘cautious’ March 12, 2026 John Lewis has returned its staff bonus after years of its suspension, as the retail titan turned a profit but remains “cautious” in a testing retail environment. The partnership, which also owns Waitrose, made a £134m profit in the year to January 2025, up six per cent from the year before, and notched growing sales [...]
The Capitalist: Lloyds teases wannabe buyers with ‘homebuying tasting menu’ March 12, 2026 Lloyds launches a dining special, private jets welcome puppies on board and City AM takes home gold; catch up on the latest City gossip.
Is the City still sexy? March 12, 2026 The era of the long boozy lunch and male dominated pints down the pub may be over, but relationships matter more than ever in the Square Mile, says Eva sayers Over glasses of red and lunch at The Quality Chop House (not recommended for vegetarians, like myself), a broker who’s been working in the City [...]
Xsolla Releases New Industry Report Identifying the Biggest Opportunities for the Future of Video Games for Developers March 11, 2026 The Xsolla Report Reveals How Studios Are Unlocking New Revenue, Reaching Global Audiences, and Building Durable Competitive Advantages
Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan March 11, 2026 Japan is one of the world's most important pharmaceutical markets after the US and Europe. Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, including a blockbuster drug. The agreement with Neupharma includes upfront and milestone payments of up to CHF 83.5 million as well as royalties of up to 20% on sales. The population of available patients eligible for corticorelin treatment associated with peritumoral brain edema is estimated at 60,000 in Japan and 500,000 worldwide. Global market potential is forecasted to exceed USD 1 billion annually.